Patent Assignment
Reel/Frame 017888/0795
Change of Name
Recorded: 2006-07-05
Pages: 4
Assignor
SYN X PHARMA INC.
Executed: 2006-02-09
Assignee
NANOGEN POINT OF CARE INC.
1 MARMAC DRIVE, TORONTO, ONTARIO, M9W 1E7, CANADA
Covered Property
(1)
Biopolymer marker indicative of disease state having a molecular weight of 1424 daltons
Application:
09/845,726 →
Publication:
US 2002/0160417
Related Assignments
(7)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Apr 10, 2002
From: JACKOWSKI, GEORGE; THATCHER, BRAD; MARSHALL, JOHN; YANTHA, JASON
To: SYN X PHARMA
Reel/Frame 012816/0777 →
Assignment of Assignor's Interest
Aug 20, 2002
From: JACKOWSKI, GEORGE; THATCHER, BRAD; STANTON, ERIC B.; VREES, TAMMY
To: SYN X PHARMA
Reel/Frame 013206/0406 →
Security Agreement
Jul 18, 2003
From: SYNX PHARMA INC.
To: CANADA TRUST COMPANY, THE
Reel/Frame 014242/0790 →
Security Interest
Feb 12, 2004
From: SYNX PHARMA INC.
To: NANOGEN, INC.
Reel/Frame 014337/0010 →
Assignment of Assignor's Interest
Aug 31, 2006
From: NANOGEN POINT OF CARE INC.
To: NANOGEN INC.
Reel/Frame 018223/0537 →
Assignment of Intellectual Property Security Agreement
Apr 15, 2008
From: THE CANADA TRUST COMPANY
To: NANOGEN, INC.
Reel/Frame 020807/0247 →
Release of Security Interest
Apr 17, 2008
From: NANOGEN POINT OF CARE, INC.
To: NANOGEN, INC.
Reel/Frame 020826/0087 →